Sandbox/general: Difference between revisions
< Sandbox
No edit summary |
No edit summary |
||
Line 96: | Line 96: | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Erythromycin]] base or ethyl succinate syrup 12.5 mg/kg q6h x 14 days'''''<BR> OR <BR> ▸ '''''[[Azithromycin ]] suspension 20 mg/kg po q24h x 3 days''''' | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Erythromycin]] base or ethyl succinate syrup 12.5 mg/kg q6h x 14 days'''''<BR> OR <BR> ▸ '''''[[Azithromycin ]] suspension 20 mg/kg po q24h x 3 days''''' | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | ''''' H. simplex (after 2-16 days)''''' | | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | ''''' H. simplex (after 2-16 days) †''''' | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Acyclovir]] 60 mg/kg/day IV divided into 3 daily doses'''''<BR> OR <BR> ▸ '''''[[Trifluridine]] OR [[Vidarabine]] as a topical antiviral therapy''''' | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Acyclovir]] 60 mg/kg/day IV divided into 3 daily doses'''''<BR> OR <BR> ▸ '''''[[Trifluridine]] OR [[Vidarabine]] as a topical antiviral therapy''''' | ||
|- | |||
|† Systemic and CNS disease should be evaluated with PCR of CSF and serum and LFTs in any child with suspected HSV eye infection. | |||
|- | |- | ||
|} | |} |
Revision as of 20:03, 3 February 2014
▸ Click on the following categories to expand treatment regimens.
Conjunctivitis Medical Therapy ▸ Bacterial Conjunctivitis ▸ Newborn Conjunctivitis Gram-Negative ▸ Gram-Negative Cocci in Pairs ▸ Gram-Negative Coccobacilli ▸ Gram-Negative Bacilli |
|